Company news

CorMedix Inc. news in 2026

CorMedix Inc.'s news releases, calls and decks from 2026, newest first.

View company

CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position

November 2, 2026

Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases

October 19, 2026

CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference

September 1, 2026

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

July 29, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

June 7, 2026

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

May 15, 2026

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

May 5, 2026

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

April 26, 2026

CorMedix to Participate in Needham Virtual Healthcare Conference

April 7, 2026

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 5, 2026

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

March 2, 2026

CorMedix Therapeutics Announces Share Repurchase Program

February 2, 2026

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

January 29, 2026

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 9, 2026

CorMedix Therapeutics Announces Leadership and Board Updates

January 8, 2026

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

January 7, 2026

Calls in 2026

Decks in 2026